Results of trial into anticoagulants for cardioversion in atrial fibrillation patients published
The results of the largest known clinical trial to investigate the use of anticoagulants prior and post cardioversion in atrial fibrillation patients, published in The Lancet, show that non-vitamin K antagonist oral anticoagulants (NOACs) could be equally as effective as the currently used warfarin.